Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs.

Lankisch MR, Ferlinz KC, Leahy JL, Scherbaum WA; Orals Plus Apidra and LANTUS (OPAL) study group.

Diabetes Obes Metab. 2008 Dec;10(12):1178-85. doi: 10.1111/j.1463-1326.2008.00967.x. Erratum in: Diabetes Obes Metab. 2010 May;12(5):461.

PMID:
19040645
2.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus.

Raccah D.

Diabetes Obes Metab. 2008 Jul;10 Suppl 2:76-82. doi: 10.1111/j.1463-1326.2008.00846.x. Review.

PMID:
18577159
5.

Insulin therapy in type 2 diabetes: what is the evidence?

van Avendonk MJ, Rutten GE.

Diabetes Obes Metab. 2009 May;11(5):415-32. doi: 10.1111/j.1463-1326.2008.00981.x. Epub 2009 Jan 19. Review.

PMID:
19175375
6.

Clinical pharmacokinetics and pharmacodynamics of insulin glulisine.

Becker RH, Frick AD.

Clin Pharmacokinet. 2008;47(1):7-20. Review.

PMID:
18076215
8.

Basal plus basal-bolus approach in type 2 diabetes.

Ampudia-Blasco FJ, Rossetti P, Ascaso JF.

Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S75-83. doi: 10.1089/dia.2011.0001. Review.

PMID:
21668340
9.

Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control.

Christiansen JS, Liebl A, Davidson JA, Ligthelm RJ, Halimi S.

Diabetes Obes Metab. 2010 Feb;12(2):105-14. doi: 10.1111/j.1463-1326.2009.01144.x. Epub 2009 Nov 5. Review.

PMID:
19895637
10.

Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis.

Han S, Iglay K, Davies MJ, Zhang Q, Radican L.

Curr Med Res Opin. 2012 Jun;28(6):969-77. doi: 10.1185/03007995.2012.684045. Epub 2012 May 3. Review.

PMID:
22494018
12.

Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.

Ristic S, Bates PC.

Diabetes Technol Ther. 2003;5(1):57-66. Review.

PMID:
12725708
13.

Insulin therapy in type 2 diabetes mellitus: a practical approach for primary care physicians and other health care professionals.

LaSalle JR, Berria R.

J Am Osteopath Assoc. 2013 Feb;113(2):152-62. Review. Erratum in: J Am Osteopath Assoc. 2013 Mar;113(3):202.

PMID:
23412677
14.

Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities.

Monnier L, Colette C.

Diabetes Metab. 2006 Feb;32(1):7-13. Review.

PMID:
16523182
15.

Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis.

Umpierre D, Ribeiro PA, Schaan BD, Ribeiro JP.

Diabetologia. 2013 Feb;56(2):242-51. doi: 10.1007/s00125-012-2774-z. Epub 2012 Nov 16. Review.

PMID:
23160642
17.

[Insulin therapy in 2011].

Perusiová J.

Vnitr Lek. 2011 Nov;57(11):930-6. Review. Czech.

PMID:
22165699
18.

Challenges in optimal metabolic control of diabetes.

Liebl A.

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S36-41. Review.

PMID:
12324984
19.
20.

[Introduction of insulin treatment on diabetes mellitus type 2].

Heljić B, Bureković A, Dizdarević-Bostandzić A.

Med Arh. 2009;63(1):51-2. Review. Bosnian.

PMID:
19419130

Supplemental Content

Support Center